
MedTech Business - December 17, 2015
Dignitana receives FDA clearance
The US Food and Drug Administration (FDA) has granted Dignitana’s de novo application to market the DigniCap scalp cooling system, designed to reduce the severity of chemotherapy-induced hair loss. After rigorous clinical studies and wide use overseas the DigniCap scalp cooling system is now FDA-cleared for use in the United States. The system, which is […]